GLP-2 intestinal trophic
Selected indexed studies
- GLP-2, EGF, and the Intestinal Epithelial IGF-1 Receptor Interactions in the Regulation of Crypt Cell Proliferation. (Endocrinology, 2020) [PMID:32147716]
- Gastrointestinal defense mechanisms. (Curr Opin Gastroenterol, 2016) [PMID:27653163]
- GLP-2: what do we know? What are we going to discover? (Regul Pept, 2014) [PMID:25218018]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- GLP-2, EGF, and the Intestinal Epithelial IGF-1 Receptor Interactions in the Regulation of Crypt Cell Proliferation. (2020) pubmed
- Gastrointestinal defense mechanisms. (2016) pubmed
- GLP-2: what do we know? What are we going to discover? (2014) pubmed
- Biased GLP-2 agonist with strong G protein-coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice. (2023) pubmed
- GLP-2 Analogues as First Specific Treatment of Intestinal Failure. (2019) pubmed
- GLP-2: A POORLY UNDERSTOOD MEDIATOR ENROLLED IN VARIOUS BARIATRIC/METABOLIC SURGERY-RELATED PATHOPHYSIOLOGIC MECHANISMS. (2016) pubmed
- Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives. (2022) pubmed
- New frontiers in the biology of GLP-2. (2000) pubmed
- New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2. (2000) pubmed
- Gastroduodenal mucosal defense mechanisms. (2015) pubmed